Risk Stratification Questionnaire
Your baseline risk determines the recommended age to begin screening and how frequently you should be tested. Answer each question honestly — there are no wrong answers.
Your Risk Stratification Result
Is Screening Right for Me?
PSA screening is a personal decision. Even for men who are candidates based on age and risk, your values and preferences matter. This short quiz helps you reflect on what screening would mean for you.
Please answer each question honestly.
Screening may not be right for you if you answer YES to either:
Question 1: Are you concerned that you would feel deeply uncomfortable knowing you have a "low-risk" cancer and not treating it, even if your doctor recommends monitoring over treatment?
Question 2: If you were found to have prostate cancer, would you definitely refuse treatment (surgery or radiation) even if your doctor recommends it?
As with all medical decisions, you are encouraged to speak with your physician about PSA prostate cancer screening and whether it may be right for you. This quiz is a tool for reflection, not a substitute for professional medical advice.
Recommended Screening Start Age & Frequency
Based on AUA/SUO Guidelines
For men in the High Risk or Intermediate Risk category, a baseline PSA >1.0 ng/mL at age 40 is a significant predictor of future life-threatening prostate cancer and warrants closer monitoring. (Ref: Lilja et al., Nat Rev Cancer, 2008)
- Screening past age 70–75 should be individualized based on a life expectancy >10 years and prior PSA trends.
- Men aged 60 or older with PSA <1.0 ng/mL have very low risk of developing metastatic or fatal prostate cancer and may not benefit from continued routine screening.
Ready to Interpret a PSA Result?
If you've already had a PSA test and want to understand what your number means — including age-adjusted thresholds, secondary biomarkers, and what questions to bring to your doctor — head to the next section.
Content reflects the American Urological Association Society of Urologic Oncology guidelines for early detection of prostate cancer.